Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
((Pneumonia OR Pulmonary OR ARDS) AND ("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV))
6,668 results
  • Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of severe COVID-19 patients. [Letter]
    Br J Haematol. 2020 Jun 01 [Online ahead of print]Caccamo N, Sullivan LC, … Dieli F
  • SARS-CoV-2 is spreading worldwide, and is a pandemic virus that has infected almost 5 million individuals and causing 300.000 deaths, as of mid-May 2020. Because SARS-CoV-2 is a new virus in humans there are currently no vaccines, monoclonal antibodies (mAbs) or even effective drugs available. Human convalescent plasma transfusion is an option for either prophylactic or therapeutic treatment of C…
  • SARS-CoV-2 Antibody Testing - Questions to be asked. [Journal Article]
    J Allergy Clin Immunol. 2020 May 29 [Online ahead of print]Özçürümez MK, Ambrosch A, … COVID-19 Task Force of theGerman Society for Clinical Chemistry and Laboratory Medicine (DGKL)
  • SARS-CoV-2 infection and development of COVID-19 disease presents a major healthcare challenge of global dimensions. Laboratory diagnostics of infected patients, and the assessment of immunity against the SARS-CoV-2 virus presents a major cornerstone in handling the pandemic. Currently there is an increase in demand of antibody testing and a large number of tests are already marketed or in the la…
  • Mesenchymal Stem Cell-based Therapy for COVID-19: Possibility and Potential. [Journal Article]
    Curr Stem Cell Res Ther. 2020 Jun 01 [Online ahead of print]Xiong J, Bao L, … Shi Y
  • A novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged in Wuhan, China since the end of December 2019 and has quickly spread all over the world in a matter of two months. To date, no specific treatment has been proven to be effective for coronavirus disease 2019 (COVID-19). With the rapid increase of infected patients and deaths, it is urgent to explo…
  • Psoriatic Arthritis and COVID-19 Pandemic: Consequences in Medical Treatment? [Journal Article]
    Dermatol Ther. 2020 Jun 01 [Online ahead of print]Wollina U, Fioranelli M, … Lotti T
  • The COVID-19 pandemic has a strong negative impact on human society world-wide. Patients with immune-mediated disease may be prone to an increased risk of infection and/ or more severe course. We review the available data for patients with psoriatic arthritis (PSA) and systemic treatments. Current treatment options are summarized. Based upon the experience with COVID-19 the following problems are…
  • Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19. [Case Reports]
    J Ultrasound Med. 2020 Jun 01 [Online ahead of print]Yassa M, Birol P, … Tug N
  • Lung ultrasound (LUS) is an effective tool to detect and monitor patients infected with 2019 coronavirus disease (COVID-19). The use of LUS on pregnant women is an emerging trend, considering its effectiveness during the outbreak. Eight pregnant women with a diagnosis of COVID-19 confirmed by nasal/throat real-time reverse transcription polymerase chain reaction testing who underwent point-of-car…
  • Pediatric coronavirus disease 2019 (COVID-19): An insight from west of Iran. [Journal Article]
    North Clin Istanb. 2020; 7(3):284-291.Soltani J, Sedighi I, … Nahidi S
  • CONCLUSIONS: COVID-19 is not uncommon in children and could have different presentations. Concomitant use of RT-PCR and chest CT scans in symptomatic cases recommended as a modality of choice to diagnose the disease. Routine laboratory tests, like many other viral infections, may not show significant or specific changes. The superimposed bacterial infection seems not the determinant of clinical outcomes as most patients had a negative evaluation by specific laboratory tests for bacterial infections; got improved dramatically with a short or no antibiotic therapy.
  • The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey. [Journal Article]
    North Clin Istanb. 2020; 7(3):203-209.Karacan I, Akgun TK, … Doganay GD
  • CONCLUSIONS: Here, we report the viral genomes circulating in Istanbul for the first time. Further sequencing of the virus isolates may enable us to understand variations in disease presentation and association with viral factors if there is any. In addition, the sequencing of more viral genomes will delineate the spread of disease and will guide and ease the necessary measures taken to stem the spread of the novel coronavirus.
  • Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. [Review]
    World J Gastroenterol. 2020 May 21; 26(19):2323-2332.Cha MH, Regueiro M, Sandhu DS
  • The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) that causes coronavirus disease-2019 (COVID-19) is a global pandemic, manifested by an infectious pneumonia. Although patients primarily present with fever, cough and dyspnea, some patients also develop gastrointestinal (GI) and hepatic manifestations. The most common GI symptoms reported are diarrhea, nausea, vomiting, and abdomina…
  • COVID-19: ACE2centric infective disease? [Journal Article]
    Hypertension. 2020 Jun 01 [Online ahead of print]Verdecchia P, Cavallini C, … Angeli F
  • Diffuse pulmonary inflammation, endothelial inflammation and enhanced thrombosis are cardinal features of COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These features are reminiscent of several adverse reactions triggered by angiotensin II, and opposed by angiotensin1-7, in many experimental models. SARS-CoV-2 binds to ACE2 receptors and entries…
  • Empirical Treatment and Prevention of COVID-19. [Review]
    Infect Chemother. 2020 Jun 01 [Online ahead of print]Shin HS
  • The rapid spread of severe acute respiratory coronavirus syndrome 2 (SARS-CoV-2) in the population and throughout the cells within our body has been developing. Another major cycle of coronavirus disease 2019 (COVID-19), which is expected in the coming fall, could be even more severe than the current one. Therefore, effective countermeasures should be developed based on the already obtained clini…
  • The association between treatment with heparin and survival in patients with Covid-19. [Journal Article]
    J Thromb Thrombolysis. 2020 May 31 [Online ahead of print]Ayerbe L, Risco C, Ayis S
  • This study investigates the association between the treatment with heparin and mortality in patients admitted with Covid-19. Routinely recorded, clinical data, up to the 24th of April 2020, from the 2075 patients with Covid-19, admitted in 17 hospitals in Spain between the 1st of March and the 20th of April 2020 were used. The following variables were extracted for this study: age, gender, temper…
New Search Next